158 related articles for article (PubMed ID: 38370352)
1. Positive correlation between the nuclear expression of GPER and pGLI3 in prostate cancer tissues from patients with different Gleason scores.
Rico-Fuentes C; López-Pulido EI; Pérez-Guerrero EE; Godínez-Rubí M; Villegas-Pineda JC; Villanueva-Pérez MA; Sierra-Díaz E; Zepeda-Nuño JS; Pereira-Suárez AL; Ramírez-de-Arellano A
Front Endocrinol (Lausanne); 2024; 15():1333284. PubMed ID: 38370352
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer.
Gonnissen A; Isebaert S; Perneel C; McKee CM; Verrill C; Bryant RJ; Van Utterbeeck F; Lerut E; Haustermans K; Muschel RJ
BMC Cancer; 2017 Sep; 17(1):634. PubMed ID: 28877722
[TBL] [Abstract][Full Text] [Related]
3. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.
Li N; Truong S; Nouri M; Moore J; Al Nakouzi N; Lubik AA; Buttyan R
Oncogene; 2018 Apr; 37(17):2313-2325. PubMed ID: 29429990
[TBL] [Abstract][Full Text] [Related]
4. Identification of the G protein-coupled estrogen receptor (GPER) in human prostate: expression site of the estrogen receptor in the benign and neoplastic gland.
Rago V; Romeo F; Giordano F; Ferraro A; Carpino A
Andrology; 2016 Jan; 4(1):121-7. PubMed ID: 26714890
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: a retrospective study from the view point of new 2010 anatomic stage/prognostic groups.
Kim TJ; Lee JY; Hwang TK; Kang CS; Choi YJ
J Surg Oncol; 2011 Oct; 104(5):472-9. PubMed ID: 21656527
[TBL] [Abstract][Full Text] [Related]
6. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
Yang Z; Peng YC; Gopalan A; Gao D; Chen Y; Joyner AL
Dis Model Mech; 2017 Jan; 10(1):39-52. PubMed ID: 27935821
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. RCC2 promotes prostate cancer cell proliferation and migration through Hh/GLI1 signaling pathway and cancer stem-like cells.
Wang S; Lei Z; Liu W; Xiong J; Shi Y; Yang L; Gao Q; Le K; Zhang B
Biol Direct; 2023 Nov; 18(1):80. PubMed ID: 38008751
[TBL] [Abstract][Full Text] [Related]
9. SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
Bauman TM; Becka AJ; Sehgal PD; Huang W; Ricke WA
Hum Pathol; 2015 Nov; 46(11):1744-51. PubMed ID: 26344417
[TBL] [Abstract][Full Text] [Related]
10. GPER and ERα expression in abnormal endometrial proliferations.
Tica AA; Tica OS; Georgescu CV; Pirici D; Bogdan M; Ciurea T; Mogoantă SŞ; Georgescu CC; Comănescu AC; Bălşeanu TA; Ciurea RN; Osiac E; Buga AM; Ciurea ME
Rom J Morphol Embryol; 2016; 57(2):413-8. PubMed ID: 27516013
[TBL] [Abstract][Full Text] [Related]
11. Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer.
Vecchiotti D; Verzella D; Di Vito Nolfi M; D'Andrea D; Flati I; Di Francesco B; Cornice J; Alesse E; Capece D; Zazzeroni F
Cells; 2022 Jul; 11(13):. PubMed ID: 35805202
[TBL] [Abstract][Full Text] [Related]
12. Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression.
Azoulay S; Terry S; Chimingqi M; Sirab N; Faucon H; Gil Diez de Medina S; Moutereau S; Maillé P; Soyeux P; Abbou C; Salomon L; Vacherot F; de La Taille A; Loric S; Allory Y
J Pathol; 2008 Dec; 216(4):460-70. PubMed ID: 18825689
[TBL] [Abstract][Full Text] [Related]
13. β
Zhang M; Wang Q; Sun X; Yin Q; Chen J; Xu L; Xu C
Prostate; 2020 Nov; 80(15):1328-1340. PubMed ID: 32894788
[TBL] [Abstract][Full Text] [Related]
14. Role of GLI-1 in epidermal growth factor-induced invasiveness of ARCaPE prostate cancer cells.
Zhu G; Zhou J; Song W; Wu D; Dang Q; Zhang L; Li L; Wang X; He D
Oncol Rep; 2013 Aug; 30(2):904-10. PubMed ID: 23757299
[TBL] [Abstract][Full Text] [Related]
15. Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer.
Carleton NM; Zhu G; Miller MC; Davis C; Kulkarni P; Veltri RW
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1237. PubMed ID: 32587951
[TBL] [Abstract][Full Text] [Related]
16. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
[TBL] [Abstract][Full Text] [Related]
17. Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer.
Becker F; Joerg V; Hupe MC; Roth D; Krupar R; Lubczyk V; Kuefer R; Sailer V; Duensing S; Kirfel J; Merseburger AS; Brägelmann J; Perner S; Offermann A
Int J Cancer; 2020 Jan; 146(2):577-588. PubMed ID: 31271443
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.
Helpap B; Ringli D; Tonhauser J; Poser I; Breul J; Gevensleben H; Seifert HH
Pathol Oncol Res; 2016 Apr; 22(2):349-56. PubMed ID: 26563277
[TBL] [Abstract][Full Text] [Related]
19. PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.
Carleton NM; Zhu G; Gorbounov M; Miller MC; Pienta KJ; Resar LMS; Veltri RW
Prostate; 2018 May; 78(7):547-559. PubMed ID: 29520928
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
